| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.18 | 9e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.2 | 0.0006 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.075 | 0.1 |